MiNK Therapeutics, Inc. (INKT) Tops Q4 EPS by 44c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of $0.23, $0.44 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Freeport-McMoRan shares surge as copper hits record $14,694/ton
• QNB Corp. sells $254M in securities in portfolio repositioning